We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership to Launch Wireless Brain Research System

By LabMedica International staff writers
Posted on 07 Jan 2015
Neuroscience research is now going wireless with the use of a new neural activity monitoring system.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA) reported that it has established an agreement with Brown University (Providence, RI, USA) to license and market a wireless neural activity monitoring system that will free neuroscientists from the burdensome wires and cables that have hampered their research efforts for years. More...


The technology was described online December 4, 2014, in the journal Neuron. The wireless neurosensory, developed by the neuroengineering laboratory at Brown University, was found to substantially outperform all other wireless sensors currently on the market. Senior author Arto Nurmikko commented, “This device enables new types of neuroscience experiments with vast amounts of brain data wirelessly and continuously streamed from brain microcircuits.”

Blackrock first presented the system at the Society for Neuroscience’s annual meeting in Washington DC (USA), held in November 2014. The Blackrock system, which includes Brown’s technology, can transmit large amounts of data—via 96 channels at 48 Mbps—from a subject’s brain for up to 48 hours between rechargeable battery replacements. Furthermore, at only 43 g and 60 cubic centimeters, it is more compact than any other wireless brain technology.

Traditional wired neuroscience research systems restrict a person’s movement and make it tremendously hard for researchers to study sleep. Blackrock’s new wireless system eliminates such problems. “This wireless system is a major step forward in brain-interface technology,” said Prof. Florian Solzbacher, PhD, president of Blackrock Microsystems. “We’re working hard to make this technology smaller and longer-lasting. These systems can have every-day, practical uses for people, and we’re determined to make that a reality.”

Blackrock Microsystems is a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology is focused on worldwide the latest advances in brain machine interfaces, implantable bionic technologies, and epilepsy diagnostics.

Related Links:

Blackrock Microsystems
Brown University



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.